This federal contract award, valued at $1,803.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication used to treat ADHD.
The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The contract does not have a set-aside designation, indicating open competition. As a prime contractor to the federal government, AmerisourceBergen plays a critical role in supplying medical products to various military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/20/25, 10:51 AM